ArticleLivers2026

The association of cardiovascular disease (CVD) with progression of advanced fibrosis risk in patients with metabolic dysfunction-associated steatotic liver disease (MASLD).

Myra Quiroga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.